1. HBW Insight
  2. >>Beauty
  3. >>Business

UK Sunscreen Claims On ‘Negligible’ Difference In SPF Strengths Don't Add Up

 
• By Eileen Francis

Advertising Standards Authority says Green People Co. misled consumers with claims SPF 30 formulas filter out only 1% less UVB rays than SPF 50, trying to draw a negligible difference between the formulas. The claims appeared in a direct mailer and on the brand’s website in July 2019.

Close up of United Kingdom map with red pin - Travel concept - Image

Green People Co. Ltd. is correct to say SPF 30 sunscreens filter only 1% less UVB rays than SPF 50 products, but the UK firm misleads consumers by saying the slim difference doesn't affect the level of protection provided, says the Advertising Standards Authority.

The ASA advised Green People in a report published 26 February not to use advertising claims suggesting that SPF 30...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Beauty

ELC Veteran Returns To Lead Makeup, While C&D, Charlotte Tilbury Strike Promo Deals; Beauty Roundup

 
• By Eileen Francis

Lisa Sequino returns to Estee Lauder to lead the strategic direction and global growth of its makeup brands. Church & Dwight has signed up two-time Olympic Gymnast Jordan Chiles as an ambassador for its Hero Cosmetics skincare brand. Plus more beauty news in brief.

Beauty Industry: Counter Impact Of State Legislation By Connecting With Lawmakers – IBA

 
• By Eileen Francis

Beauty stakeholders will undoubtedly feel the impact of new state laws targeting cosmetic ingredients and packaging and should therefore open lines of communication with state lawmakers.

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.